Bexorg has secured $23 million in a Series A fina
Author: Michael
OcuSciences has obtained EU CE clearance for its
Placenta-derived cell therapy shows promise in pa
BellaMia Technologies, Inc.
New review defines astroimmunology as a lens on
EON.
Bexorg lands funding for platform that restores
Telomir Pharmaceuticals released preclinical data
Health-technology firm Function Health announced
Cortechs.